Pimafucort cream 15g

Pimafucort

Composition

Pimafucort - cream:

1 g of cream contains natamycin 10 mg, neomycin (as neomycin sulfate) 3500 U, micronized Hydrocortisone 10 mg; in tubes of 15 g.

Pimafucort ointment:

1 g of ointment contains natamycin 10 mg, neomycin (as neomycin sulfate) 3500 U,

hydrocortisone micronized 10 mg; in tubes of 15 g.

Mechanism of action

Antibacterial, antifungal local, anti-inflammatory local.

Indications and usage

Dermatosis, susceptible to GCS therapy, complicated by secondary bacterial and / or fungal infection (especially caused by fungi of the genus Candida).

Contraindications

hypersensitivity to Pimafucort components;

skin tuberculosis, skin manifestations of syphilis, viral infections of the skin, skin post-vaccination reactions, open wounds, ulcers;

acne, rosacea, ichthyosis;

anogenital itching, skin tumors.

Pregnancy and Breastfeeding

When prescribing Pimafucort during pregnancy, it is necessary to take into account the theoretical risk of the ototoxic effect of neomycin, and therefore it is impossible to use the drug for a long time and apply it under occlusive dressings.

Adverse reactions

Side effects from external use of Pimafucort, as with the use of other GCS, develop rarely and are reversible.

Rarely, a hypersensitivity reaction (itching, burning, redness, or dry skin) may develop.

Extremely rare - atrophy and thinning of the skin, telangiectasia, striae, purpura, rosacea-like and perioral dermatitis, delayed wound healing, depigmentation, hypertrichosis, withdrawal syndrome after stopping treatment.

When using external corticosteroids for a long time, on large areas of the skin or when using occlusive dressings, especially in children, side effects characteristic of systemic corticosteroids, such as suppression of the function of the adrenal cortex, may develop.

Contact dermatitis with neomycin.

Dosage and administration

Pimafucort used externally. For adults and children, the drug is applied to the affected skin 2-4 times a day. The duration of treatment is determined individually, taking into account the nature of the disease, the course of treatment usually does not exceed 14 days.

In children, Pimafucort is used under the supervision of a physician, the drug should be applied to limited skin areas, occlusive dressings should not be applied.

In the form of a cream, the drug is recommended for the treatment of acute and subacute dermatoses, incl. accompanied by soiling. The ointment is intended for the treatment of sub-acute and chronic dermatoses, especially in the presence of severe dry skin, lichenification, seborrhea, or in cases where the occlusive properties of the ointment are necessary.

When applying Pimafucort on the area of ​​the eyelids and periorbital area, there is a risk of increased intraocular pressure, development of cataracts.

Storage conditions

At temperatures not above 25 ° C. Shelf life - 3 years.